DAIC

MAY 6, 2024

milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.

Congenital 105

Congenital Innovation VSD Stents 105

DAIC

JANUARY 29, 2024

Romano, MD , a congenital heart surgeon at Congenital Heart Center/C. I’m ready to lead our members into this next chapter and increase our impact on the specialty and patient care.” Jennifer C. Romano, MD milla1cf Mon, 01/29/2024 - 10:46 January 29, 2024 — Jennifer C.

Congenital 105

Congenital Cardiothoracic Innovation Hospital 105

DAIC

JUNE 4, 2024

This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.

Ultrasound 111

Ultrasound Education Research Technology 111

Society of Thoracic Surgeons - Early Career

JULY 31, 2024

Participation and productivity of these groups are a foundational mechanism for the STS to improve the lives of patients living with cardiothoracic diseases through leadership, professionalism, innovation, collaboration, diversity, and inclusion. This framework is now published in The Annals of Thoracic Surgery Short Reports. (1)

Cardiothoracic 59

Cardiothoracic Academic Education Congenital 59

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

When providers and clinicians have access to the best quality data, patient care improves. After a medical device or intervention has been proven to be safe and effective and reasonable and necessary for coverage, CED requires innovators to monitor how their technology performs in the real world. Learn more at sts.org.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

DAIC

JUNE 12, 2024

RWMAs can be an independent indicator of adverse cardiovascular events and death in patients with cardiovascular diseases like myocardial infarction (MI) and congenital heart disease. Automated machine learning-based assessment of RWMA has the potential to improve the efficiency of all readers. “An

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

ADN Center of Excellence

SEPTEMBER 28, 2023

Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Advancements in Cardiology Cardiology is a dynamic field, with ongoing research and technological advancements that continue to transform patient care.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52